Fact CheckerSign in

NCT06889883Recruiting

Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer

Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer Based on Molecular Markers and Risk Factors Identified With Artificial Intelligence Tools

Source: ClinicalTrials.gov · Last updated 1 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This is a prospective, multicenter, case-control study. The aim is to develop an optimized algorithm by combining the levels of molecular markers in plasma together with risk factors for developing colorectal cancer and clinical data of patients diagnosed with CRC or AA and healthy individuals.

Status (registry)
Recruiting
Study type
Observational
Enrollment
510 (estimated)
First submitted
17 Mar 2025
Start date
6 Jun 2023
Primary completion date
31 Dec 2025
Lead sponsor
ADVANCED MARKER DISCOVERY S.L.
NCT number
NCT06889883

What you commit to

  • Study type: Observational
  • Planned participants: 510
  • From 6 Jun 2023 to the primary completion date, 31 Dec 2025
  • 9 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients who had developed any type of cancer in the 5 years prior to their participation in this study.
  • Patients who have received previous chemotherapy or radiotherapy.
  • Patients who have undergone colonoscopy/polipectomy in the previous 5 years.

Other illness

  • Patients diagnosed with non-advanced adenomas, serrated polyps, Familial Adenomatous Polyposis or Lynch Syndrome.

Other

  • Patients with inadequate bowel preparation for colonoscopy.
  • Patients with hemolyzed plasma.

Who the study is looking for

  • Patients over the age of 18 who are able to understand the participant information and sign the informed consent.
  • Patients who are going to undergo colonoscopy or surgical resection for tumor (CRC).

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (9)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital Universitario Vall d'Hebron
Coordinator of this site? Confirm its status
BarcelonaSpainCompleted
Hospital Sant Rafael
Coordinator of this site? Confirm its status
BarcelonaSpainCompleted
Hospital Universitario de Cruces
Coordinator of this site? Confirm its status
BilbaoSpainRecruiting
Policlinica Gipuzkoa Hospital
Coordinator of this site? Confirm its status
Donostia / San SebastianSpainCompleted
MD Anderson Cancer Centre
Coordinator of this site? Confirm its status
MadridSpainActive, not recruiting
Hospital Centro Médico de Asturias
Coordinator of this site? Confirm its status
OviedoSpainRecruiting
Hospital Universitario De Salamanca
Coordinator of this site? Confirm its status
SalamancaSpainRecruiting
Hospital Universitario Marqués de Valdecilla
Coordinator of this site? Confirm its status
SantanderSpainTerminated
Hospital Clinico Universitario Lozano Blesa
Coordinator of this site? Confirm its status
ZaragozaSpainRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.